M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 1.91 USD -3.54% Market Closed
Market Cap: 90.3m USD
Have any thoughts about
MDxHealth SA?
Write Note

Profitability Summary

MDxHealth SA's profitability score is 22/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score
22/100
Profitability
Score
High Profitability Stocks
Biotechnology Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Margins Comparison
MDxHealth SA Competitors

Country Company Market Cap Net
Margin
BE
MDxHealth SA
NASDAQ:MDXH
90.3m USD
-50%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-21 040%
US
Abbvie Inc
NYSE:ABBV
302.3B USD
9%
US
Amgen Inc
NASDAQ:AMGN
160.6B USD
13%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-392%
AU
CSL Ltd
ASX:CSL
138.5B AUD
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD
34%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
33.4B EUR
-14%
Country BE
Market Cap 90.3m USD
Net Margin
-50%
Country FR
Market Cap 6T USD
Net Margin
-21 040%
Country US
Market Cap 302.3B USD
Net Margin
9%
Country US
Market Cap 160.6B USD
Net Margin
13%
Country US
Market Cap 126.3B USD
Net Margin
-5%
Country US
Market Cap 118.3B USD
Net Margin
0%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country AU
Market Cap 138.5B AUD
Net Margin
18%
Country US
Market Cap 90.4B USD
Net Margin
34%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country NL
Market Cap 33.4B EUR
Net Margin
-14%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
MDxHealth SA Competitors

Country Company Market Cap ROE ROA
BE
MDxHealth SA
NASDAQ:MDXH
90.3m USD
-664%
-43%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
US
Abbvie Inc
NYSE:ABBV
302.3B USD
56%
4%
US
Amgen Inc
NASDAQ:AMGN
160.6B USD
56%
5%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD
-3%
-2%
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD
1%
0%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
AU
CSL Ltd
ASX:CSL
138.5B AUD
16%
7%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD
17%
13%
US
Seagen Inc
F:SGT
39.3B EUR
-28%
-21%
NL
argenx SE
XBRU:ARGX
33.4B EUR
-8%
-7%
Country BE
Market Cap 90.3m USD
ROE
-664%
ROA
-43%
Country FR
Market Cap 6T USD
ROE
115%
ROA
-391%
Country US
Market Cap 302.3B USD
ROE
56%
ROA
4%
Country US
Market Cap 160.6B USD
ROE
56%
ROA
5%
Country US
Market Cap 126.3B USD
ROE
-3%
ROA
-2%
Country US
Market Cap 118.3B USD
ROE
1%
ROA
0%
Country US
Market Cap 94.1B EUR
ROE
-877%
ROA
-67%
Country AU
Market Cap 138.5B AUD
ROE
16%
ROA
7%
Country US
Market Cap 90.4B USD
ROE
17%
ROA
13%
Country US
Market Cap 39.3B EUR
ROE
-28%
ROA
-21%
Country NL
Market Cap 33.4B EUR
ROE
-8%
ROA
-7%

See Also

Discover More
Back to Top